Point72 Asset Management L.P. Acquires 95,030 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Point72 Asset Management L.P. grew its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 63.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 245,340 shares of the medical instruments supplier's stock after buying an additional 95,030 shares during the period. Point72 Asset Management L.P. owned approximately 1.00% of ICU Medical worth $38,069,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd bought a new position in shares of ICU Medical in the 4th quarter worth $33,000. Quarry LP increased its position in shares of ICU Medical by 764.3% during the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after purchasing an additional 214 shares during the last quarter. Murphy & Mullick Capital Management Corp purchased a new stake in ICU Medical in the 4th quarter worth about $52,000. Venturi Wealth Management LLC increased its holdings in ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 300 shares during the last quarter. 96.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ICUI. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Raymond James lowered their price objective on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a report on Friday, May 9th. KeyCorp cut their price target on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, ICU Medical presently has a consensus rating of "Buy" and an average price target of $192.67.

ICU Medical Stock Down 2.2%

Shares of ICUI traded down $3.08 on Tuesday, reaching $134.92. The stock had a trading volume of 218,866 shares, compared to its average volume of 277,444. The firm has a market capitalization of $3.32 billion, a price-to-earnings ratio of -29.52 and a beta of 0.87. The company has a 50-day simple moving average of $140.78 and a 200-day simple moving average of $153.61. ICU Medical, Inc. has a 12-month low of $100.91 and a 12-month high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.49. The company had revenue of $599.49 million for the quarter, compared to analysts' expectations of $574.15 million. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.96 earnings per share. Sell-side analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current year.

Insider Transactions at ICU Medical

In other news, COO Christian B. Voigtlander sold 5,555 shares of the stock in a transaction on Monday, May 19th. The stock was sold at an average price of $138.00, for a total value of $766,590.00. Following the sale, the chief operating officer now directly owns 2,389 shares of the company's stock, valued at approximately $329,682. This represents a 69.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Elisha W. Finney sold 600 shares of the stock in a transaction on Monday, May 19th. The stock was sold at an average price of $138.92, for a total value of $83,352.00. Following the completion of the sale, the director now directly owns 3,252 shares in the company, valued at approximately $451,767.84. This represents a 15.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 21,208 shares of company stock valued at $2,926,969. Insiders own 1.50% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.